Emerging Understanding of the Advantage of Small Molecules such as Hydroxypyridinones in the Treatment of Iron Overload

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|12|1051-1064

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.12, 2003-06, pp. : 1051-1064

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New chelation therapies and emerging chelating drugs for the treatment of iron overload

By Kontoghiorghes George J  

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 1-5

Informa Healthcare

Access to resources Recommend Favorite

Chelating Agents for the Treatment of Systemic Iron Overload

By  

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2816-2827

Bentham Science Publishers

Access to resources Recommend Favorite

New Pharmacological Concepts for the Treatment of Iron Overload Disorders

By  

Current Medicinal Chemistry, Vol. 16, Iss. 5, 2009-02 ,pp. : 576-590

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecules in Treatment of Sepsis

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-02 ,pp. : 256-262

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload

By Cappellini MD   Taher A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2391-2402

Informa Healthcare

Access to resources Recommend Favorite